A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop ...
Hosted on MSN
Next-gen flu vaccines use proteolysis-targeting to boost safety and cross-strain immunity in animal models
Recently, Prof. Si Longlong's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a library of live-attenuated influenza A vaccines that utilize ...
PROTAR viruses efficiently reproduce owing to TEVp-mediated viral protein stabilization in TEVp-expressing cells and are attenuated by proteasome-mediated viral protein degradation in conventional ...
A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated ...
Please provide your email address to receive an email when new articles are posted on . Most transplant recipients developed and maintained protective antibodies up to 1 year after varicella or MMR ...
Efforts to develop a live-attenuated malaria vaccine are advancing. In this report, an engineered sporozoite-based vaccine is presented in a human challenge model, with associated immunologic ...
Long regarded as disease-specific, some widely used vaccines may confer broader health benefits that extend beyond protection against intended pathogens. Evidence suggests that certain live attenuated ...
Researchers at Texas Biomedical Research Institute have developed a new, proof-of-concept vaccine to protect people from the bird flu strain currently circulating in the United States. The team, led ...
Hosted on MSN
Needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes
A research team led by the School of Public Health in the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with the Center for Immunology & Infection (C2i), has achieved ...
A research team led by the School of Public Health in the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with the Centre for Immunology & Infection (C2i), has achieved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results